ciprofloxacin has been researched along with Bladder, Overactive in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Women with overactive bladder and urodynamic diagnosis of detrusor overactivity who were refractory to anticholinergics, and had histological evidence of urothelial inflammation were treated with a 6-week course of rotating antibiotics." | 1.39 | Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder. ( Cartwright, R; Derpapas, A; Fernando, R; Gallo, P; Khullar, V; Vijaya, G, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, MH | 1 |
| Baldo, O | 1 |
| Koenig, P | 1 |
| Shaikh, N | 1 |
| Vijaya, G | 1 |
| Cartwright, R | 1 |
| Derpapas, A | 1 |
| Gallo, P | 1 |
| Fernando, R | 1 |
| Khullar, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Treatment of Overactive Bladder: a Randomized Controlled Trial[NCT05519072] | Phase 4 | 140 participants (Anticipated) | Interventional | 2022-08-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for ciprofloxacin and Bladder, Overactive
| Article | Year |
|---|---|
Use of prophylactic antibiotics for intra-vesicle Botox® injection.
Topics: Acetylcholine Release Inhibitors; Administration, Intravesical; Anti-Bacterial Agents; Antibiotic Pr | 2017 |
Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Cephalexin; Ciprofloxacin; Cohort Studies; Doxycycline; Fe | 2013 |